Anti-Staphylococcus aureus immunotherapy: current status and prospects.
Immunological prophylaxis and therapy for Staphylococcus aureus are attractive goals. However, there is nothing currently available in the clinic. Several approaches have failed and more are being undertaken. Here we assess current progress and the potential for success.
García-Lara
Jorge
J
Absynth Biologics Ltd, The Bioincubator, Sheffield S3 7RD, UK.
Foster
Simon J
SJ
D000818:Animals; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D018579:Patient Selection; D013203:Staphylococcal Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control / Q000628:therapy*; D013209:Staphylococcal Vaccines / Q000737:chemistry; D013211:Staphylococcus aureus / Q000276:immunology* / Q000472:pathogenicity; D017211:Treatment Failure
D013209:Staphylococcal Vaccines